Merck Kgaa Adr Stock Return On Equity
| MKKGY Stock | USD 31.07 0.21 0.67% |
Merck KGaA ADR fundamentals help investors to digest information that contributes to Merck KGaA's financial success or failures. It also enables traders to predict the movement of Merck Pink Sheet. The fundamental analysis module provides a way to measure Merck KGaA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merck KGaA pink sheet.
Merck |
Merck KGaA ADR Company Return On Equity Analysis
Merck KGaA's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Merck KGaA Return On Equity | 0.14 |
Most of Merck KGaA's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Merck KGaA ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Merck KGaA ADR has a Return On Equity of 0.1422. This is 100.59% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 145.87% lower than that of the firm.
Merck Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merck KGaA's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Merck KGaA could also be used in its relative valuation, which is a method of valuing Merck KGaA by comparing valuation metrics of similar companies.Merck KGaA is currently under evaluation in return on equity category among related companies.
Merck Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0656 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 92.22 B | |||
| Shares Outstanding | 2.17 B | |||
| Shares Owned By Institutions | 0.03 % | |||
| Price To Earning | 33.17 X | |||
| Price To Book | 2.75 X | |||
| Price To Sales | 3.86 X | |||
| Revenue | 19.69 B | |||
| Gross Profit | 12.36 B | |||
| EBITDA | 5.95 B | |||
| Net Income | 3.06 B | |||
| Cash And Equivalents | 1.71 B | |||
| Cash Per Share | 0.79 X | |||
| Total Debt | 7.93 B | |||
| Debt To Equity | 0.45 % | |||
| Current Ratio | 1.28 X | |||
| Book Value Per Share | 12.98 X | |||
| Cash Flow From Operations | 4.62 B | |||
| Earnings Per Share | 1.72 X | |||
| Price To Earnings To Growth | 3.07 X | |||
| Target Price | 44.0 | |||
| Number Of Employees | 63.72 K | |||
| Beta | 0.65 | |||
| Market Capitalization | 88.17 B | |||
| Total Asset | 45.36 B | |||
| Z Score | 6.6 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.14 % | |||
| Net Asset | 45.36 B | |||
| Last Dividend Paid | 1.85 |
About Merck KGaA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Merck KGaA ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck KGaA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck KGaA ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck KGaA ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Merck KGaA ADR information on this page should be used as a complementary analysis to other Merck KGaA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Merck Pink Sheet analysis
When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |